Effect of budesonide/formoterol in chronic obstructive pulmonary disease patients with low peak inspiratory flow rate
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000009174
- Lead Sponsor
- Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Infections with no available effective antimicrobial drugs or with deep mycosis 2) A history of hypersensitivity (including contact dermatitis)to any ingredient contained in budesonide/formoterol 3) Tuberculosis 4) Case with the following complications a) Severe liver disease b) Severe renal disease 5) Planning-to-be-pregnant, pregnant or lactating patients 6) Inappropriate case considered by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of various indicators 1) Respiratory Function (FEV1,% FEV1) 2) CAT (COPD Assessment Test) score
- Secondary Outcome Measures
Name Time Method Airway resistance (R5, R20, R5-R20) Change of HADS (Hospital Anxiety and Depression Scale) Safety